Browse by category

Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio

Olympus has launched two new jaw designs in the Powerseal Sealer/Divider range of advanced bipolar surgical energy products: the...

Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity

Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with...

iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss

iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing...

Unjury Protein launches Protect & Restore Advanced Protein+ to reduce side effects of GLP-1 RAs

Unjury Protein has launched its Protect & Restore Advanced Protein+ - the first clinically supported medical food and co-therapy for...

Phenomix Sciences launches three-in-one obesity phenotyping test

Phenomix Sciences has launched a new MyPhenome test that now allows patients to test for all three identified phenotypes - Emotional...

Spatz3 Adjustable Gastric Balloon launched in the US

Spatz Medical has announced the launch of the Spatz3 Adjustable Gastric Balloon in the US. The Spatz3 Adjustable Gastric Balloon,...

Zepbound (tirzepatide) available in US pharmacies for adults living with obesity

Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...

Olympus launches POWERSEAL Sealer/Divider, a next level surgical bipolar energy device in EMEA

Olympus has announced the full market launch of POWERSEAL Sealer/Divider for the Europe, Middle East and Africa (EMEA) region. This...

Dynarex launches Bari+Max line of premium bariatric products

Dynarex has launched its Bari+Max line of premium bariatric products meticulously designed to meet the needs of today's bariatric...

Allurion gains approval to launch Elipse Balloon in Brazil

Allurion has received approval from the Brazilian Health Regulatory Agency (ANVISA) to launch its Elipse Balloon, the world’s first and...

2 3

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

5 hours ago

Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes

1 day ago

Serotonin plays key role in the development of post-bariatric hypoglycaemia

1 day ago

Browse by category

Browse by tag

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net